Summary
The inhibitory effect of triamterene and its metabolites on human leucocyte dihydrofolate reductase has been studied. Under test conditions with dihydrofolic acid 0.5×10−5 M, triamterene 7×10−5 M produced total enzyme inhibition, whereas the metabolites hydroxytriamterene and the sulphate ester of hydroxytriamterene were less effective inhibitors; at their maximum attainable concentration of 5×10−5 M, dihydrofolate reductase was inhibited by 80% and 50%, respectively. Cultures of the BJAB-B95-8 human lymphoma cell line were incubated with various concentrations of triamterene. Because of their increased specific activity of dihydrofolate reductase, the cells were able to maintain normal DNA metabolism, as measured by the ratio of the incorporation rates of 3H-deoxyuridine and 3H-thymidine, as well as normal cell growth at 1×10−6 M, and in some cases at 1 × 10−5 M triamterene. At 8×10−5 M triamterene, the strong inhibitory effect caused severe impairment of DNA metabolism and subsequently dissolution of the cell culture. The results are discussed in relation to the possible toxic side effects of long-term triamterene treatment in patients suffering from alcoholic cirrhosis, who may have impaired metabolism of triamterene and a concomitant severe folate deficiency.
References
Bertino JR (1977) “Rescue” techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment. Semin Oncol 4: 203–216
Corcino J, Waxman S, Herbert V (1970) Mechanism of triamterene-induced megaloblastosis. Ann Intern Med 73: 419–424
Fresen KO, zur Hausen H (1976) Establishment of EBNA-expressing cell lines by infection with different EBV strains. Int J Cancer 17: 161–166
Goldman ID (1975) Membrane transport of methotrexate (NSC-740) and other folate compounds: relevance to rescue protocols. Cancer Chemother Rep (Part 3) 6: 62–72
Goldman ID (1977) Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction. Cancer Treat Rep 61: 549–558
Grebian B, Geißler HE, Mutschler E (1976) Uber die Bestimmung von Triamteren, Hydroxytriamteren und Hydroxytriamteren-schwefelsäure-ester in biologischem Material durch direkte Auswertung von Dünnschichtchromatogrammen. Drug Res 26: 2125–2127
Grebian B, Geißler HE, Knauf H, Mutschler E, Schnippenkoetter I, Völger K, Wais U (1978) Zur Pharmakokinetic von Triamteren und seinen wirksamen Metaboliten bei eingeschränkter Nierenfunktion. Drug Res 28: 1420–1425
Klein H (1975) Triamteren: Klinische Pharmakologie, Indikationsbereiche und Nebenwirkungen eines Diuretikums. Therapiewoche 25: 5135–5142
Lieberman FL, Bateman JR (1968) Megaloblastic anemia possibly induced by triamterene in patients with alcoholic cirrhosis. Ann Intern Med 68: 168–173
Michal G (1974) Bestimmung von Michaelis-Konstanten und Inhibitor-Konstanten. In: Bergmeyer HU (ed) Methoden der enzymatischen Analyse, 3. Aufl., Vol. I. Verlag Chemie, Weinheim/Bergstraße, pp 153–165
Möhrke W, Mutschler E, Schalhorn, A, Völger KD (1980) In preparation
Müller-Herman R (1979) Vergleichende pharmakokinetische Untersuchungen von Triamteren und seinen Metaboliten bei Gesunden und Patienten mit Leberzirrhose. Dissertation, Frankfurt/Main
Niethammer D, Jackson RC (1976) The effect of trimethoprim on cellular transport of methotrexate and its cytotoxicity to human lymphoblastoid cells in vitro. Br J Haematol 32: 273–281
Renoux M, Bernard JF, Amar M, Boivin P (1976) Pancytopénie aigue et mégaloblastose médullaire chez un cirrhotique traité par le triamtérène. Nouv Presse Méd 5: 641–642
Sauer H, Schalhorn A, Wilmanns W (1979) The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate. Eur J Cancer 15: 1203–1209
Siegert W, Moar MH, Bell C, Klein G (1977) Demonstration of complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography. Cell Immunol 31: 234–241
Warren RD, Nichols AP, Bender RA (1978) Membrane transport of methotrexate in human lymphoblastoid cells. Cancer Res 38: 668–671
Wilmanns W (1962) Bestimmung, Eigenschaften und Bedeutung der Dihydrofolatreduktase in den weißen menschlichen Blutzellen bei Leukämien. Klin Wochenschr 40: 533–540
Wilmanns W, Hamfelt A (1964) Medikamentös bedingte Störungen der Blutzellreifung durch Hemmung der Enzyme des Folsäurestoffwechsels. Verh Dtsch Ges Inn Med 70: 586
Wilms K, Wiedmann KH, Castrillon-Oberndorfer WL (1979) Schwere megaloblastäre Anämie durch Triamteren bei einem Patienten mit alkoholischer Leberzirrhose. Dtsch Med Wochenschr 104: 814–817
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schalhorn, A., Siegert, W. & Sauer, H.J. Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line. Eur J Clin Pharmacol 20, 219–224 (1981). https://doi.org/10.1007/BF00544601
Issue Date:
DOI: https://doi.org/10.1007/BF00544601